Global Oncolytic Virus Competitive Landscape Professional Research Report 2025

Global Oncolytic Virus Competitive Landscape Professional Research Report 2025

Research Summary

An oncolytic virus is a type of virus that has been engineered or naturally evolved to selectively infect and kill cancer cells while sparing healthy cells. These viruses can efficiently target and replicate within cancer cells, ultimately leading to their destruction. Oncolytic viruses can be derived from various virus families, including adenoviruses, herpesviruses, reoviruses, and others. When used as a therapeutic agent, oncolytic viruses are often modified to enhance their safety, target specificity, and anticancer potency. They can be administered directly into tumor sites, intravenously, or via other routes depending on the specific virus and cancer type being targeted. Once inside the cancer cells, the oncolytic viruses infect and replicate, causing the cancer cells to burst and release viral particles that can further infect neighboring cancer cells. In addition to direct tumor cell lysis, oncolytic viruses can also stimulate the immune system to mount an immune response against the cancer, further aiding in tumor eradication. Oncolytic viruses are being actively researched and developed as a promising therapeutic approach for various types of cancers, either as standalone treatments or in combination with other therapies.

According to DIResearch's in-depth investigation and research, the global Oncolytic Virus market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Oncolytic Virus include Amgen, Shanghai Sunway Biotech etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Oncolytic Virus. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Oncolytic Virus market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Oncolytic Virus market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oncolytic Virus industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Oncolytic Virus Include:

Amgen

Shanghai Sunway Biotech

Oncolytic Virus Product Segment Include:

Imlygic

Oncorine

Others

Oncolytic Virus Product Application Include:

Melanoma

Other Cancers

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Oncolytic Virus Industry PESTEL Analysis

Chapter 3: Global Oncolytic Virus Industry Porter’s Five Forces Analysis

Chapter 4: Global Oncolytic Virus Major Regional Market Size and Forecast Analysis

Chapter 5: Global Oncolytic Virus Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Oncolytic Virus Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Oncolytic Virus Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Oncolytic Virus Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Oncolytic Virus Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Oncolytic Virus Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Oncolytic Virus Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Oncolytic Virus Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources